Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,094 public trials 2,044 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma

NCT01234766

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Maine Center for Cancer Medicine Scarborough, Maine, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Rhode Island Hospital Providence, Rhode Island, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • Charles University Hospital Prague, Czechia
  • Hopital Debrousse Lyon, France
  • Haematologisch Onkologische Praxis Aachen, Germany
View all 338 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00053768

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Specialist Practice for Oncology Aschaffenburg, Germany
View all 175 locations
View Trial Details
Completed

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

NCT02500550

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations
  • Algemeen Ziekenhuis Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Gasthuisberg Leuven, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
View Trial Details
Completed

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

NCT01100502

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 87 locations
View Trial Details
Completed

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

NCT01419665

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Investigative site La Plata, Argentina
  • Investigative site Rosario, Argentina
  • Investigative site San Miguel de Tucumán, Argentina
  • Investigative site Adelaide, Australia
View all 153 locations
View Trial Details

Related conditions